Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.
2.

The generation of enzymatically active plasmin on the surface of spirochetes.

Coleman JL, Benach JL.

Methods. 2000 Jun;21(2):133-41.

PMID:
10816374
3.

Borrelia burgdorferi induces secretion of pro-urokinase-type plasminogen activator by human monocytes.

Fuchs H, Simon MM, Wallich R, Bechtel M, Kramer MD.

Infect Immun. 1996 Oct;64(10):4307-12.

4.

Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi.

Klempner MS, Noring R, Epstein MP, McCloud B, Hu R, Limentani SA, Rogers RA.

J Infect Dis. 1995 May;171(5):1258-65.

PMID:
7751701
5.

The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor.

Fuchs H, Wallich R, Simon MM, Kramer MD.

Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12594-8.

6.

Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers.

Coleman JL, Sellati TJ, Testa JE, Kew RR, Furie MB, Benach JL.

Infect Immun. 1995 Jul;63(7):2478-84.

7.

Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Garbisa S.

Cancer Res. 1981 Nov;41(11 Pt 1):4629-36.

8.

Complement regulator-acquiring surface protein 1 of Borrelia burgdorferi binds to human bone morphogenic protein 2, several extracellular matrix proteins, and plasminogen.

Hallström T, Haupt K, Kraiczy P, Hortschansky P, Wallich R, Skerka C, Zipfel PF.

J Infect Dis. 2010 Aug 15;202(3):490-8. doi: 10.1086/653825.

PMID:
20565259
9.

Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin.

Silverstein RL, Harpel PC, Nachman RL.

J Biol Chem. 1986 Jul 25;261(21):9959-65.

10.

Plasminogen acquisition and activation at the surface of leptospira species lead to fibronectin degradation.

Vieira ML, Vasconcellos SA, Gonçales AP, de Morais ZM, Nascimento AL.

Infect Immun. 2009 Sep;77(9):4092-101. doi: 10.1128/IAI.00353-09. Epub 2009 Jul 6.

11.

Binding of human urokinase type plasminogen activator and plasminogen to Borrelia species.

Klempner MS, Noring R, Epstein MP, McCloud B, Rogers RA.

J Infect Dis. 1996 Jul;174(1):97-104.

PMID:
8656020
13.

Regulation of protease nexin-1 target protease specificity by collagen type IV.

Donovan FM, Vaughan PJ, Cunningham DD.

J Biol Chem. 1994 Jun 24;269(25):17199-205.

14.

Interaction of spirochetes with the host fibrinolytic system and potential roles in pathogenesis.

Vieira ML, Nascimento AL.

Crit Rev Microbiol. 2016 Aug;42(4):573-87. doi: 10.3109/1040841X.2014.972336. Epub 2015 Apr 27. Review.

PMID:
25914944
15.
16.
17.

Plasmin is not protective in experimental renal interstitial fibrosis.

Edgtton KL, Gow RM, Kelly DJ, Carmeliet P, Kitching AR.

Kidney Int. 2004 Jul;66(1):68-76.

18.
19.

HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI.

Rao CN, Cook B, Liu Y, Chilukuri K, Stack MS, Foster DC, Kisiel W, Woodley DT.

Int J Cancer. 1998 May 29;76(5):749-56.

20.

Binding of human plasminogen to Borrelia burgdorferi.

Hu LT, Perides G, Noring R, Klempner MS.

Infect Immun. 1995 Sep;63(9):3491-6.

Supplemental Content

Support Center